IL6 and COVID-19: Indeed, the association between high IL-6 concentration (> 80 pg/mL) and respiratory failure and/or death has been confirmed in several studies and posed the rationale for the use of IL-6 blockers in the management of patients with severe COVID-19 (12, 13).